Cost-effectiveness of diagnostic strategies for patients with chest pain

Annals of Internal Medicine

Volumn 130, Issue 9, 1999, Pages 709-718

  Kuntz, Karen M ^b   Fleischmann, Kirsten E ^b   Hunink, Maria G M ^b   Douglas, Pamela S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; ECHOCARDIOGRAPHY; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX PAIN;

EID: 0033522482     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-130-9-199905040-00002     Document Type: Article

References (48)

1. Elveback LR, Connolly DC, Kurland LT. Coronary heart disease in residents of Rochester, Minnesota. II. Mortality, incidence, and survivorship, 1950-1975. Mayo Clin Proc. 1981;56:665-72.
2. Chaitman BR, Bourassa MG, Davis K, Rogers WJ, Tyras DH, Berger R, et al. Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation. 1981;64:360-7.
3. Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A, et al. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation. 1989;80:87-98.
4. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276:1172-7.
5. Doubilet P, McNell BJ, Weinstein MC. The decision concerning coronary angiography in patients with chest pain. A cost-effectiveness analysis. Med Decis Making. 1985;5:293-309.
6. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13:322-38.
7. Hilborne LH, Leape LL, Kahan JP, Park RE, Kamberg CJ, Brook RH. Percutaneous Transluminal Coronary Angioplasty: A Literature Review and Ratings of Appropriateness and Necessity. Santa Monica, CA: RAND; 1991.
8. Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA. 1998;280:913-20.
9. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563-70.
10. Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med. 1984;310:750-8.
11. Wong JB, Sonnenberg FA, Salem DN, Pauker SG. Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Ann Intern Med. 1990;113:852-71.
12. Myers WO, Gersh BJ, Fisher LD, Mock MB, Holmes DR, Schaff HV, et al. Time to first new myocardial infarction in patients with mild angina and three-vessel disease comparing medicine and early surgery: a CASS registry study of survival. Ann Thorac Surg. 1987;43:599-612.
13. Mark DB, Nelson CL, Califf RM. Harrell FE, Lee KL, Jones RH, et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation. 1994;89:2015-25.
14. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation. 1983;68:939-50.
15. King SB 3d, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med. 1994;331:1044-50.
16. Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB 3d, Hamm CW, et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet. 1995;346:1184-9.
17. Lee TH, Fukui T, Weinstein MC, Tosteson AN, Goldman L. Cost-effectiveness of screening strategies for left main coronary artery disease in patients with stable angina. Med Decis Making. 1988;8:268-78.
18. Ryan T, Segar DS, Sawada SG, Berkovltz KE, Whang D, Dohan AM, et al. Detection of coronary artery disease with upright bicycle exercise echocardiography, J Am Soc Echocardiogr. 1993;6:186-97.
19. Palmas W, Friedman JD, Diamond GA, Silber H, Kiat H, Berman DS. Incremental value of simultaneous assessment of myocardial function and perfusion with technetium-99m sestamibi for prediction of extent of coronary artery disease. J Am Coll Cardiol. 1995;25:1024-31.
20. m-sestamibi SPECT with coronary angiography in general hospital practice. Nucl Med Commun. 1993;14:23-9.
21. Miranda CP, Lehmann KG, Lachterman B, Coodley EM, Froelicher VF. Comparison of silent and symptomatic ischemia during exercise testing in men. Ann Intern Med. 1991;114:649-56.
22. Johnson LW, Lozner EC, Johnson S, Krone R, Pichard AD, Vetrovec GW, et al. Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. I. Results and complications. Cathet Cardiovasc Diagn. 1989;17:5-10.
23. Lozner EC, Johnson LW, Johnson S, Krone R, Pichard AD, Vetrovec GW, et al. Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. II. An analysis of 218 deaths related to coronary arteriography. Cathet Cardiovasc Diagn. 1989;17: 11-4.
24. Holmes DR Jr, Holubkov R, Vlietstra RE, Kelsey SF, Reeder GS, Dorros G, et al. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol. 1988;12:1149-55.
25. Yusuf S, Zucker D, Chalmers TC. Ten-year results of the randomized control trials of coronary artery bypass graft surgery: tabular data compiled by the collaborative effort of the original trial investigators. Part 1 of 2. Online J Curr Clin Trials. 1994;14:document no. 144.
26. Yusuf S, Zucker D, Chalmers TC. Ten-year results of the randomized control trials of coronary artery bypass graft surgery: tabular data compiled by the collaborative effort of the original trial investigators. Part 2 of 2. Online J Curr Clin Trials. 1994;14:document no. 145.
27. Hannan EL, Kilburn H Jr, O'Donnell JF, Lukacik G, Shields EP. Adult open heart surgery in New York State. An analysis of risk factors and hospital mortality rates. JAMA. 1990;264:2768-74.
28. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med. 1994;331:1037-43.
29. Rodriguez A, Boullon F, Perez-Balino N, Pavlotti C, Liprandi MI, Palacious IF. Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group. J Am Coll Cardiol. 1993;22:1060-7.
30. Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet. 1993;341:573-80.
31. Nwasokwa ON, Koss JH, Friedman GH, Grunwald AM, Bodenheimer MM. Bypass surgery for chronic stable angina: predictors of survival benefit and strategy for patient selection. Ann Intern Med. 1991;114:1035-49.
32. Califf RM, Mark DB, Harrell FE Jr, Hlatky MA, Lee KL, Rosati RA, et al. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. J Am Coll Cardiol. 1988;11:20-6.
33. De Servi S, Berzuini C, Poma E, Ferrario M, Ghio S, Scire A, et al. Long-term survival and risk stratification in patients with angina at rest undergoing medical treatment, Int J Cardiol. 1989;22:43-50.
34. Chaitman BR, Ryan TJ, Kronmal RA, Foster ED, Frommer PL, Killip T. Coronary Artery Surgery Study (CASS): comparability of 10 year survival in randomized and randomizable patients. J Am Coll Cardiol. 1990;16:1071-8.
35. Brunelli C, Cristofani R, L'Abbate A. Long-term survival in medically treated patients with ischemic heart disease and prognostic importance of clinical and electrocardiographic data (the Italian CNR Multicentre Prospective Study OD1). Eur Heart J. 1989;10:292-303.
36. Lawrie GM, Morris GC Jr, Baron A, Norton J, Glaeser DH. Determinants of survival 10 to 14 years after coronary bypass: analysis of preoperative variables of 1,448 patients. Ann Thorac Surg. 1987;44:180-5.
37. Adler DS, Goldman L, O'Nell A, Cook EF, Mudge GH Jr, Shemin RJ, et al. Long-term survival of more than 2,000 patients after coronary artery bypass grafting. Am J Cardiol. 1986;58:195-202.
38. National Center for Health Statistics. Vital Statistics of the United States, 1988. Volume II. Mortality, Part A. Washington, DC: Public Health Service; 1991.
39. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation. 1983;68:951-60.
40. Nease RF Jr, Kneeland T, O'Connor GT, Sumner W, Lumpkins C, Shaw L, et al. Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team. JAMA. 1995;273:1185-90.
41. Lave JR, Pashos CL, Anderson GF, Brailer D, Bubolz T, Conrad D, et al. Costing medical care: using Medicare administrative data. Med Care. 1994; 32(7 Suppl):JS77-89.
42. Stinnett AA, Mittleman MA, Weinstein MC, Kuntz KM, Cohen DJ, Williams LW, et al. The cost-effectiveness of dietary and pharmacologic therapy for cholesterol reduction in adults. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford Univ Pr; 1996:349-91.
43. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach. Med Decis Making. 1985;5:157-77.
44. Pryor DB, Shaw L, McCants CB, Lee KL, Mark DB, Harrell FE Jr, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med. 1993;118:81-90.
45. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300:1350-8.
46. Mark DB, Hlatky MA, Harrell FE Jr, Lee KL, Califf RM, Pryor DB. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med. 1987;106:793-800.
47. Katz DA, Cronenwett JL. The cost-effectiveness of early surgery versus watchful waiting in the management of small abdominal aortic aneurysms. J Vase Surg. 1994;19:980-91.
48. Goldman L, Weinstein MC, Goldman PA, Williams LW. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 1991;265:1145-51.